Pharmafile Logo
Pharmafocus logo
Advanced Search

CDF

Showing 15 posts of 62 posts found.

Three new entries to Cancer Drugs Fund

February 5, 2014
Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo

Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …

News
CDF image

Cancer Drugs Fund: assessing a difficult legacy

February 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty

England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …

Feature

The CDF: friend and foe?

November 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low

Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …

Feature

SMC must be ‘more flexible’ – health minister

October 9, 2013
Sales and Marketing CDF, NICE, SMC

The Scottish health secretary Alex Neil has announced a series of fundamental changes to improve access to new medicines in …

News

Cancer survival rates linked to government spending in EU

October 1, 2013
Research and Development, Sales and Marketing CDF, Cancer, EU, NICE

The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …

News
hunt image

Cancer Drugs Fund to run until 2016

September 30, 2013
Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP

England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …

News
NHS image

Cancer Drugs Fund to stay, government to announce

September 27, 2013
Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister

The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …

News
NICE image

‘Inequality’ for Welsh cancer patients

August 28, 2013
Sales and Marketing CDF, Cancer, England, NHS, NICE, Wales

Cancer sufferers in England are four times more likely to receive newer treatments on the NHS than patients in Wales, …

News
Haslam image

David Haslam: a new chairman for a new NICE

June 24, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Hasmam, NHS, NICE

When NICE was first set up in 1999, technology appraisals of new medicines were its sole focus, but over the …

Feature

Sanofi cleared in sales row

September 20, 2012
Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi

Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …

News

Cancer Drugs Fund ‘the wrong choice’ for Wales

May 29, 2012
Sales and Marketing CDF, Cancer, NHS, Wales, Welsh

The Welsh health minister Lesley Griffiths has said that a Cancer Drugs Fund is ‘not the right course’ for Wales. …

News

Government to speed up access to new cancer drugs

April 24, 2012
Sales and Marketing CDF, Cancer, Roche, UK, avastin, government, sha

Access to England’s Cancer Drugs Fund will be speeded up, ministers have confirmed.  Currently, it can take a number of …

News
Zelboraf image

Roche’s melanoma pill launched in UK

March 14, 2012
Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf

Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer.  Zelboraf (vemurafenib) is the …

News
Zytiga image

Cancer Drugs Fund should not be used across the UK

March 7, 2012
Sales and Marketing CDF, Janssen, NICE, Zytiga, myloma, prostate

The Prostate Cancer Charity has said that extending England’s Cancer Drugs Fund to the UK will not solve the issue …

News
Zytiga image

Zytiga approved in Wales – for now

February 21, 2012
Sales and Marketing AWMSG, CDF, Janssen, NICE, Wales, Zytiga

Janssen’s cancer treatment Zytiga has been approved in Wales, in contrast to its rejection by NICE. The All Wales Medicines …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026